Laurus Labs recorded steep decline in revenue growth & net profit in FY15

By Joseph Rai

  • 07 Jun 2016
Premium
research-1029340_640.jpg

Vishakhapatnam-based drug ingredients maker Laurus Labs, which has true-blue private equity firm Warburg Pincus on board as an investor and is now planning an initial public offer, saw its revenue growth slowing phenomenally in 2014-15 vis-à-vis the previous two financial years. The company also recorded a steep decline of close ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.